NCT07171827
- Conditions
- Advanced Classical Hodgkin Lymphoma, Anti-CD30, Brentuximab, +4 more
- Locations
-
- Helwan University Helwan, Egypt
Clinical trial condition
Anti-CD30
Explore clinical trials studying Anti-CD30. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies